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Abstract 
Background: Menopause is associated with changes in sexual function which are partly due to vaginal 
atrophy in response to estrogen reduction. Estrogen administration temporarily reduces the symptoms of 
vaginal dryness, but long-term exposure to this drug is likely to be associated with serious complications. 
Considering the promising results of previous studies concerning the effect of vitamin D on vaginal dryness, 
the proposed study will investigate the effect of vitamin D vaginal suppository on the sexual function of 
postmenopausal women. 
Methods: In a randomized, controlled clinical trial, 105 postmenopausal women will be randomly assigned 
to three groups receiving vitamin D vaginal suppository, placebo vaginal suppository, or control (no 
intervention). Vitamin D vaginal suppositories contain 1000 units of vitamin D3. The timing of the use of 
vitamin D vaginal suppositories and placebo suppositories will be every night in the first 2 weeks, and every 
other night in the following 6 weeks (8 weeks in total). The primary outcome will be the sexual function of 
participants which will be assessed using the Female Sexual Function Index (FSFI) before and immediately 
after the intervention, and at 1 and 2 months after the end of the intervention. The side effects of these 
suppositories will be examined as a secondary consequence of the study. Data will be analyzed using SPSS 
software version 25. In the case of normal distribution of data, the mean score of sexual function will be 
compared between the groups using a repeated measurements ANOVA. If statistical analysis leads to 
significant results, the post-hoc test will be used to determine the differences between the groups. 
Comparison of demographic and fertility characteristics of the women will be carried out using statistical 
tests such as chi-squares and t-tests. A significance level of p < .05 will be used for statistical analyses. 
Discussion: If vitamin D vaginal suppositories improve sexual function among premenopausal women 
with longterm effects and minimum side effects, the suppositories will be considered a safe complementary 
and alternative choice for alleviating sexual dysfunction among this group. 
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